This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. Read our cookie policy for more information. Click here to accept the use of cookies on our website. Home Careers Contact us Print ABOUT US PRODUCT PIPELINE RESEARCH AND TECHNOLOGY PARTNERING INVESTORS MEDIA Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. View Our Latest Presentations Access our latest presentations including a webcast of our presentation at the Bank of America Merrill Lynch Global Healthcare Conference 2014 on September 19 as well as scientific posters and presentations in our Download Library. Envisioning the Future of Cancer Treatment: A Video with CEO Jan van de Winkel Genmab's CEO shares his perspective on how the company's work to develop innovative antibody therapeutics could change the lives of cancer patients in the future. Click here to watch the video. Genmab Opens Doors to Innovation Genmab is inviting researchers in academia and industry to experience the full power of the DuoBody® platform for bispecific antibody research and drug development. Explore the possibilities via our recently published Perspective in the journal mAbs and the renewed Open Innovation section on DuoBody.com. LATEST NEWS Genmab to Present at the Bank of America Merrill Lynch Global Healthcare conference 2014 Seattle Genetics and Genmab Enter Into New Antibody-Drug Conjugate Collaboration Major Shareholder Announcement Genmab Announces Financial Results for the First Half of 2014 and Improves 2014 Financial Guidance More Genmab News Releases OUR MOTIVATION At the heart of Genmab is a deep desire to improve the quality of life for cancer patients. Click here to watch our video about our fight against cancer. STOCK INFO STOCK PRICE as of 10/17/2014 12:00 AM (CET) SHARE PRICE DKK 232.40 CHANGE (IN DKK) 14.20 VOLUME 253786 Stock Information About us Product pipeline Partnering Research and technology Investors Media Careers Contact us © 2014 Genmab A/S Accessibility policy Cookie policy Disclaimer Sitemap

Genmab Careers Contact Us Print ABOUT US PRODUCT PIPELINE PARTNERING TECHNOLOGY INVESTORS MEDIA Home Error There is some error happened in the server. Please contact administrator or try again later. About Us Product Pipeline Partnering Technology Investors Media Careers Contact Us © 2011 Genmab A/S Accessibility policy Privacy policy Disclaimer Sitemap